Skip to Main Content
upf.edu
  • Studies
  • Research
  • Knowledge transfer
  • Services
  • University
Information addressed to ...
  • Prospective students
  • Alumni
  • International students
  • Companies and organizations
  • Media
Contact Online office
En
CG
Campus Global
RDI Portfolio
  • Areas of knowledge
    • Health and Life Sciences
    • Information & Communication Technologies
    • Social Sciences and Humanities
  • Type of content
    • Technologies / Software
    • Patents
    • Research groups
    • Spin-off
  • About
More ...
RDI Portfolio
  • Areas of knowledge
    • Health and Life Sciences
    • Information & Communication Technologies
    • Social Sciences and Humanities
  • Type of content
    • Technologies / Software
    • Patents
    • Research groups
    • Spin-off
  • About
upf.edu
  • Studies
  • Research
  • Services
  • University
Information addressed to...
  • Prospective students
  • Alumni
  • International students
  • Companies and organizations
  • Media
Contact
Menú
En
CG
Campus Global
  • inici /
  • Content
  • /
  • Research Group - Inhibitory and activating receptors of the innate immune system

Research Group - Inhibitory and activating receptors of the innate immune system

The Research Group on Human Natural Killer Cell Biology is led by Dr. Miguel López-Botet, Professor of Immunology at University Pompeu Fabra (UPF) and head of the Immunology Service at Hospital del Mar. The research laboratory is located at the UPF premises in Barcelona Biomedical Research Park (PRBB). 

The team has a long-standing and internationally recognized experience on the biology of human Natural Killer (NK) cells, which are involved in the immune response against infections and tumors.

The role of NK cells in the response to human cytomegalovirus (HCMV) is currently being studied. HCMV infection may cause severe congenital neurological disorders in newborns, and constitutes a common complication for immunocompromised individuals (e.g transplant recipients). Our attention is oriented to: a) unravel the mechanism(s) of this pattern of adaptive NK cell response to the viral infection; b) explore its implications in the immune response to other pathogens and tumors, as well as in the pathophysiology of inflammatory disorders.

Research group website

Related Assets

  • Technology / Software - Hybridoma cell lines secreting monoclonal antibodies (Ref. TEC0072)
Connect
  • Innovation Unit - UPF Business Shuttle
  • Contact
  • Our team
Follow us
Tech transfer office
  • The Innovation Unit - UPF Business Shuttle manages the transfer of the research results and capabilities shown in this website.

© Universitat Pompeu Fabra
Barcelona
T.(+34) 93 542 20 00

  • Legal notice
  • Accessibility
  • Technical note

We use cookies to deliver personalized content, analyze trends, administer the site, track user movements on the site, and collect demographic information about our user base as a whole. Accept all cookies for the best possible experience on our website or manage your preferences. Legal notice